Ad is loading...
JVMRX
Price
$31.39
Change
-$0.23 (-0.73%)
Updated
Nov 15 closing price
LMCHX
Price
$38.08
Change
-$0.32 (-0.83%)
Updated
Nov 15 closing price
Ad is loading...

JVMRX vs LMCHX

Header iconJVMRX vs LMCHX Comparison
Open Charts JVMRX vs LMCHXBanner chart's image
JHancock Disciplined Value Mid Cap R6
Price$31.39
Change-$0.23 (-0.73%)
VolumeN/A
CapitalizationN/A
Lord Abbett Mid Cap Stock R6
Price$38.08
Change-$0.32 (-0.83%)
VolumeN/A
CapitalizationN/A
JVMRX vs LMCHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVMRX vs. LMCHX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMRX is a Buy and LMCHX is a Buy.

FUNDAMENTALS
Fundamentals
JVMRX has more cash in the bank: 23.8B vs. LMCHX (1.23B). JVMRX pays higher dividends than LMCHX: JVMRX (0.93) vs LMCHX (0.70). JVMRX was incepted earlier than LMCHX: JVMRX (13 years) vs LMCHX (9 years). JVMRX (41.00) and LMCHX (41.00) have comparable annual turnover. LMCHX has a lower initial minimum investment than JVMRX: LMCHX (0) vs JVMRX (1000000). LMCHX annual gain was more profitable for investors over the last year : 29.31 vs. JVMRX (21.74). JVMRX return over 5 years is better than : 45.54 vs. LMCHX (38.68).
JVMRXLMCHXJVMRX / LMCHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years9 years-
Gain YTD14.73018.96478%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets23.8B1.23B1,938%
Annual Yield % from dividends0.930.70133%
Returns for 1 year21.7429.3174%
Returns for 3 years7.785.59139%
Returns for 5 years45.5438.68118%
Returns for 10 years63.39N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LQR1.000.10
+10.94%
LQR House
GRBK69.45-0.50
-0.71%
Green Brick Partners
EXAS49.33-1.60
-3.14%
Exact Sciences Corp
EVER17.80-1.01
-5.37%
EverQuote
ADVM6.86-0.39
-5.38%
Adverum Biotechnologies